Ionic Capital Management LLC decreased its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 63.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 121,601 shares of the company's stock after selling 215,183 shares during the quarter. Perrigo accounts for 0.3% of Ionic Capital Management LLC's portfolio, making the stock its 16th largest position. Ionic Capital Management LLC owned about 0.09% of Perrigo worth $3,126,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the company. Headlands Technologies LLC boosted its holdings in Perrigo by 1,942.0% in the fourth quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock worth $36,000 after purchasing an additional 1,340 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Perrigo by 93.7% in the 4th quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after buying an additional 929 shares during the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Perrigo by 97.8% in the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company's stock worth $108,000 after acquiring an additional 2,084 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Perrigo during the fourth quarter valued at $149,000. Finally, Sterling Capital Management LLC lifted its holdings in Perrigo by 51.8% in the fourth quarter. Sterling Capital Management LLC now owns 8,144 shares of the company's stock valued at $209,000 after acquiring an additional 2,780 shares during the period. 95.91% of the stock is currently owned by hedge funds and other institutional investors.
Perrigo Stock Performance
NYSE PRGO traded down $0.25 on Wednesday, reaching $25.97. 1,356,830 shares of the stock were exchanged, compared to its average volume of 1,536,182. The company's 50-day simple moving average is $26.30 and its two-hundred day simple moving average is $26.14. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $3.57 billion, a PE ratio of -22.20 and a beta of 0.45. Perrigo Company plc has a one year low of $23.14 and a one year high of $30.93.
Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.04. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company had revenue of $1.04 billion for the quarter, compared to analysts' expectations of $1.09 billion. During the same period in the previous year, the firm earned $0.29 EPS. The firm's revenue was down 3.5% compared to the same quarter last year. Analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.
Perrigo Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be paid a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 4.47%. The ex-dividend date is Friday, May 30th. Perrigo's payout ratio is -88.55%.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on PRGO shares. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. StockNews.com cut Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $33.00.
View Our Latest Report on Perrigo
Insider Buying and Selling at Perrigo
In other news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. The trade was a 18.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.40% of the stock is owned by company insiders.
Perrigo Company Profile
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.